Versar awarded $7.6M contract to review and evaluate pesticide product

Versar, Inc. (NYSE Amex:VSR) announced today that it was awarded a five-year, $7.6 million contract to review and evaluate pesticide product and residue chemistry data by the Office of Pesticide Programs (OPP), Health Effects Division (HED), of the U.S. Environmental Protection Agency (EPA). The EPA's award of this new contract to Versar increases the total number of contracts to six currently managed by Versar's Exposure and Risk Assessment Division.

Under this new contract, Versar will review and evaluate product and residue chemistry data for the registration and re-registration of pesticides; perform data analysis and database development; and prepare technical presentations. The support under this contract will assist the OPP under their regulatory mandates, and will continue Versar's more than 20 years of support to the EPA's pesticide exposure assessment programs.

Tony Otten, CEO of Versar, said, "Versar continues to expand our funded backlog with the win of important new contracts. While Versar has worked with the EPA's pesticides program for two decades, this win moves us into new areas and scientific disciplines. The EPA's pesticides programs are among the EPA's highest priorities to better characterize chemical exposures and risks to our communities. Versar brings innovative approaches and rigorous scientific analysis to support EPA's programs that ensure the safety of all our citizens."

Source:

Versar, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
22 pesticides found to be associated with prostate cancer incidence in the United States